[gdlr_core_space height=”50px”] [gdlr_core_social_network linkedin=”https://www.linkedin.com/company/cannim” email=”contact@cannim.com”] [gdlr_core_space height=”30px”]
The NIIM has made an announcement on changes to the AP approval process with the following implications:
- Brand-based HREC approvals will move to schedule-based approvals
- Via an amendment form, healthcare professionals will be able to switch to the new system
Inter alia, the announcement reads:
- “The TGA would accept ethics approvals for medicinal cannabis products according to the TGA Schedule of the products, rather than each product’s trade name.”
- “The NIIM HREC will accept schedule-based APS ethics applications.
This is welcome news for the industry as it minimises bureaucratic hurdles for prescribers, opening up a wider range of products for cannabis patients.
For the full announcement, please follow this link: https://lnkd.in/gXKShqKm
#healthcare #medicinalcannabis #regulatorycompliance
_
